Pharma channel feed

As­traZeneca pulls pa­tient da­ta ex­posed on code shar­ing site GitHub

3 years ago

Mod­er­na's stock plunges in pre­mar­ket trad­ing as Ban­cel promis­es com­pa­ny is in 'much bet­ter place' for FY23 de­liv­er­ies

3 years ago

Texas CD­MO is cut­ting 60% of staff as fo­cus shifts to drug dis­cov­ery, in-house can­di­dates

3 years ago
Manufacturing

GSK touts record Shin­grix sales as Zan­tac cas­es go to tri­al

3 years ago

What caus­es hot flash­es? Astel­las ramps up ed­u­ca­tion­al cam­paign ahead of FDA de­ci­sion

3 years ago
Marketing

FDA warn­ing let­ters de­tail is­sues for man­u­fac­tur­ing sites in the US and In­dia

3 years ago
FDA+
Manufacturing

No­vo Nordisk drops two pro­grams as it plots We­govy come­back

3 years ago

Al­lo­gene Over­land Bio­pharm com­pletes Shang­hai fa­cil­i­ty to man­u­fac­ture CAR-T prod­ucts

3 years ago
Cell/Gene Tx
Manufacturing

Up­dat­ed: GSK nabs pri­or­i­ty re­view on RSV vac­cine, kicks off show­down with Pfiz­er — while 'set­ting the bar high' on R&D

3 years ago
R&D

Amid rev­enue dip, Pfiz­er CEO Al­bert Bourla is fo­cused on 'what's nex­t'

3 years ago

Eli Lil­ly plans to make tirzepatide next big thing as phar­ma ex­pe­ri­ences 'un­prece­dent­ed' de­mand for the drug

3 years ago

#CPHI22: As Sam­sung’s new plant comes on­line, it looks to ex­pand in Ko­rea and be­yond

3 years ago
Manufacturing

HHS re­news 'call to ac­tion' with Covid boost­er ad spots

3 years ago
Coronavirus
Marketing

Col­lege ath­lete deals and phar­ma? Dex­com tests the wa­ters in a first move that opens new spokesper­son doors for in­dus­try

3 years ago
Marketing

Mar­ket­ingRx roundup: Mod­er­na clues in to ‘Jeop­ardy’; BMS, Gilead build out clin­i­cal tri­al di­ver­si­ty pro­gram

3 years ago
Marketing

Bris­tol My­er­s' block­buster-to-be Re­blozyl scores a PhI­II win

3 years ago

Dai­ichi Sankyo sets new highs for As­traZeneca-part­nered can­cer drug En­her­tu

3 years ago

FDA to kick off CMC readi­ness pi­lot pro­gram next April

3 years ago
FDA+
Manufacturing

Ab­b­Vie puts up fight against Orilis­sa gener­ics from San­doz, Te­va and oth­ers

3 years ago
Law

GSK warns 50+ crowd to ‘wake up’ to vi­ral dan­ger of shin­gles in lat­est cam­paign

3 years ago
Marketing

Cit­ing too many da­ta con­founders, FDA ad­comm unan­i­mous­ly votes against Y-mAb­s' drug for rare brain can­cer

3 years ago
FDA+

Paul Hud­son pre­dicts de­layed im­pact on Sanofi from Biden's IRA, as Dupix­ent beats last quar­ter's sales

3 years ago

Up­dat­ed: A short­age of amox­i­cillin is now be­ing re­port­ed by sev­er­al man­u­fac­tur­ers

3 years ago
Manufacturing

EMA lim­its use of JAK in­hibitors for at-risk groups in wake of safe­ty con­cerns

3 years ago
FDA+
First page Previous page 163164165166167168169 Next page Last page
A service from the Financial Times